Trial intelligence / Profile preview

Prediction of Efficacy of Oral Trileptal (Oxcarbazepine) by Intravenous Lidocaine Infusion in Neuropathic Pain

TCTR20141029001Phase 2Active, not recruiting

Sponsor
Siriraj Research Development Fund
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of oxcarbazepine, lidocaine in Neuralgia, sponsored by Siriraj Research Development Fund. Started Dec 2013; status: active, not recruiting.

02

Drugs

oxcarbazepinelidocaine
03

Conditions

Neuralgia

Beyond the preview

Go deeper on TCTR20141029001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20141029001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call